Paying user area
Try for free
Gilead Sciences Inc. pages available for free this week:
- Income Statement
- Cash Flow Statement
- Analysis of Profitability Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Debt to Equity since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Gilead Sciences Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Income Statement
12 months ended: | Product sales | Operating income (loss) | Net income (loss) attributable to Gilead |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Product Sales
- The product sales exhibited a generally upward trend from 2005 to 2024 with a few notable fluctuations. There was steady growth from $1,809 million in 2005 to a peak of $32,151 million in 2014, representing significant expansion over this period. After hitting this peak, sales declined gradually for several years, dropping to $21,677 million in 2018. Subsequently, sales recovered moderately, reaching $28,610 million by 2024, though this value remains slightly below the 2014 peak. The data indicates periods of strong growth followed by a phase of moderate decline and subsequent partial recovery.
- Operating Income (Loss)
- Operating income followed a somewhat volatile pattern over the years, initially rising from $1,111 million in 2005 to $3,962 million in 2010. Noteworthy is a sharp loss in 2006 amounting to -$759 million, which stands out as a significant anomaly. After recovery, operating income peaked at $22,193 million in 2014, correlating with the peak in product sales. Post-2014, operating income declined markedly, reaching lows such as $1,662 million in 2024. This decline suggests challenges in maintaining profitability despite relatively stable sales later on. The trend suggests substantial operating leverage effects and potential cost pressures impacting income levels in later years.
- Net Income Attributable to Gilead
- Net income showed variability and some volatility consistent with operating income trends. Starting at $814 million in 2005, net income plunged to a loss of -$1,190 million in 2006, similar to operating income's negative result that year. Recovery followed with net income rising to $18,108 million in 2014, corresponding to the peak period of product sales and operating income. In the years after 2014, net income experienced a notable decline and fluctuation, with values dropping below $1,000 million in some years including 2020 and 2024. The decline in net income after 2014 parallels operating income trends and suggests challenges with profitability, possibly influenced by costs, impairments, or other financial factors. This volatility highlights a period of financial instability or restructuring following peak earnings years.
- Overall Financial Trends and Insights
- The data reveals an initial phase of rapid growth in sales, earnings, and profitability culminating roughly around 2014. Beyond this peak, a period of financial stress emerges, marked by declining operating income and net income, despite relatively stable product sales compared to earlier years. This suggests that while revenue generation remained strong, underlying profitability was challenged, possibly due to increased costs, competitive pressures, or other operational issues. The partial recovery in sales toward 2024 without a commensurate profit recovery underscores ongoing margin pressure. These trends indicate a maturing business encountering increased challenges to sustain its earlier growth and profitability levels.
Balance Sheet: Assets
Current assets | Total assets | |
---|---|---|
Dec 31, 2024 | ||
Dec 31, 2023 | ||
Dec 31, 2022 | ||
Dec 31, 2021 | ||
Dec 31, 2020 | ||
Dec 31, 2019 | ||
Dec 31, 2018 | ||
Dec 31, 2017 | ||
Dec 31, 2016 | ||
Dec 31, 2015 | ||
Dec 31, 2014 | ||
Dec 31, 2013 | ||
Dec 31, 2012 | ||
Dec 31, 2011 | ||
Dec 31, 2010 | ||
Dec 31, 2009 | ||
Dec 31, 2008 | ||
Dec 31, 2007 | ||
Dec 31, 2006 | ||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The analysis of the financial data reveals notable trends in both current assets and total assets over the examined period.
- Current Assets
-
Current assets exhibited significant fluctuations throughout the years. Initially, between 2005 and 2007, the figures rose from approximately $3.1 billion to just over $3 billion, followed by a steep increase to $4.8 billion by the end of 2009. A pronounced peak occurred in 2011 when current assets surged to nearly $14 billion, likely indicating a strategic accumulation or acquisition-related activity.
Subsequently, current assets experienced a sharp decline in 2012 to around $6.2 billion, then gradual growth resumed reaching a high of approximately $35.8 billion in 2018. This peak was followed by a downward adjustment to about $15.9 billion in 2020 and relatively stable but slightly fluctuating levels in the subsequent years, ending with an increase to roughly $19.2 billion by the end of 2024.
The volatility in current assets suggests periods of aggressive investment or divestment, alongside possible inventory and receivables management variations, reflecting shifts in operational strategies and liquidity management.
- Total Assets
-
Total assets demonstrated a consistent positive growth trend over the period with varying growth rates. Starting at around $3.8 billion in 2005, there was a steady increase reaching approximately $7 billion by the end of 2008. Growth accelerated in the following years, culminating in a significant jump to nearly $52 billion in 2015.
This upward trajectory continued, with total assets peaking at about $70.3 billion in 2017 before experiencing moderate declines and fluctuations between $61.6 billion and $68.4 billion from 2018 through 2021. The assets showed a decreasing trend afterward, falling to approximately $59 billion by 2024.
The general expansion in total assets reflects sustained investment in fixed and intangible assets, acquisitions, or growth in business operations. The post-2017 moderation may indicate consolidation phases or asset revaluation impacts.
Balance Sheet: Liabilities and Stockholders’ Equity
Gilead Sciences Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
Current liabilities | Total debt and other obligations, net | Total Gilead stockholders’ equity | |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Current Liabilities
- The current liabilities exhibit a general upward trend over the period under review. Starting from US$455 million in 2005, there is a substantial increase to US$1,872 million by 2009, demonstrating rapid growth in short-term obligations. Following this, the liabilities continue to rise, reaching a peak of US$11,635 million in 2017. There is a slight decline and fluctuation after this peak, with values oscillating around US$11,000 million from 2018 to 2023, ending with a marginal increase to approximately US$12,004 million in 2024.
- Total Debt and Other Obligations, Net
- This item shows significant variability throughout the years. Starting at US$301 million in 2005, the value surges sharply to US$1,400 million in 2006, then fluctuates slightly before a notable increase to US$7,606 million in 2011. The upward movement continues, peaking at US$33,542 million in 2017, which marks the highest level recorded. After this peak, a downward trend is apparent, with the debt decreasing to around US$24,987 million by 2023, followed by a small rebound to US$26,711 million in 2024. This pattern indicates periods of large financing activities or borrowings, followed by partial reductions or repayments.
- Total Gilead Stockholders’ Equity
- Stockholders’ equity rises from US$3,028 million in 2005 to US$6,367 million by 2009, showing steady growth. Following a slight dip to US$5,864 million in 2010, equity increases again, reaching US$18,534 million in 2014. The upward progression continues until it peaks around US$22,525 million in 2019. Afterward, a decline is observed to US$18,202 million in 2020, followed by moderate recovery and stabilization near US$21,000 to US$23,000 million in subsequent years. The latest figure in 2024 shows a reduction to US$19,330 million, suggesting some volatility in equity possibly due to market conditions or corporate actions.
- Overall Observations
- The data reveal that liabilities and debt increased significantly over the years, especially peaking around 2017 before partially moderating. Stockholders' equity also grew but experienced more fluctuations, particularly after 2019. The simultaneous peak in debt and liabilities around 2017 suggests a period of aggressive financing or investment, while the later stabilization and slight reduction point to efforts in managing or restructuring the financial obligations. The changes in equity correspond partially with these liability trends, reflecting the impact of these financial strategies on the company's net worth.
Cash Flow Statement
12 months ended: | Net cash provided by operating activities | Net cash (used in) provided by investing activities | Net cash provided by (used in) financing activities |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Operating Activities
- The net cash provided by operating activities shows a general upward trend from 2005 through 2014, growing from $715 million to a peak of $20,329 million in 2014. Following this peak, there is a noticeable decline until 2018, reaching $8,400 million. After 2018, there are fluctuations with intermittent recovery phases, including an increase to $11,384 million in 2021, followed by declines and increases, ending at $10,828 million in 2024. This trend indicates significant growth in operating cash flows during the early period, followed by volatility and moderate recovery in recent years.
- Investing Activities
- The net cash used in investing activities generally shows substantial outflows across the period, with some exceptions. Notably, investing cash flows were negative in most years, with considerable outflows in 2012 (-$11,846 million), 2015 (-$12,475 million), and 2016 (-$11,985 million). However, there are occasional positive inflows observed in 2011 ($3,590 million) and 2018 ($14,355 million), indicating asset disposals or other investing inflows during these years. Overall, the investing activities reflect frequent and large cash investments or asset acquisitions, punctuated by occasional liquidations or returns from investments.
- Financing Activities
- Net cash provided by (used in) financing activities fluctuates prominently throughout the period. Early years show net inflows, peaking at $649 million in 2006. From 2007 onwards, cash flows from financing activities often turn negative, with significant outflows in years such as 2008 (-$1,536 million), 2014 (-$3,025 million), and 2016 (-$9,347 million). There are intermittent periods of positive cash flows, such as in 2011 ($1,764 million) and 2017 ($3,393 million), but the overall pattern points to a reliance on financing outflows, likely representing debt repayments, share repurchases, or dividend payments.
- Summary of Cash Flow Trends
- The company demonstrates a strong ability to generate cash from operations, especially between 2005 and 2014, after which operating cash inflows become more variable. Investing activities consistently show large cash outflows, indicating ongoing investment in long-term assets despite occasional inflows. Financing activities are characterized by variable cash flows, with a predominance of outflows in the latter part of the period, suggesting active management of capital structure through repayments and shareholder distributions. Together, these trends suggest a company that has grown substantially in operating cash generation, maintained significant investment activities, and adjusted its financing strategies dynamically over time.
Per Share Data
12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
---|---|---|---|
Dec 31, 2024 | |||
Dec 31, 2023 | |||
Dec 31, 2022 | |||
Dec 31, 2021 | |||
Dec 31, 2020 | |||
Dec 31, 2019 | |||
Dec 31, 2018 | |||
Dec 31, 2017 | |||
Dec 31, 2016 | |||
Dec 31, 2015 | |||
Dec 31, 2014 | |||
Dec 31, 2013 | |||
Dec 31, 2012 | |||
Dec 31, 2011 | |||
Dec 31, 2010 | |||
Dec 31, 2009 | |||
Dec 31, 2008 | |||
Dec 31, 2007 | |||
Dec 31, 2006 | |||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The financial data reveals several notable trends in the earnings per share (EPS) for the analyzed periods. Basic earnings per share started at $0.45 in 2005, followed by a decline to negative values in 2006 at -$0.65, indicating a loss. From 2007 onwards, a general upward trend is observable, peaking significantly in 2014 and 2015 with values of $7.95 and $12.37 respectively. However, after this peak, a decline ensued, with some fluctuations, leading to a low of $0.10 in 2020. The EPS then recovered moderately in the following years, reaching $4.54 in 2023, before dropping again to $0.38 in 2024.
The diluted earnings per share exhibited a pattern very similar to the basic earnings per share, with initial losses in 2006, a strong growth phase peaking in 2014 and 2015 at $7.35 and $11.91 respectively, followed by a decline and partial recovery. The lowest diluted EPS also occurred in 2020 at $0.10, mirroring the trend in basic EPS, and the value dropped again to $0.38 in 2024.
Regarding dividends per share, no payments were made during the initial period through 2013. Starting in 2014, dividends were introduced at $1.29, followed by a consistent increase each year through 2024, reaching $3.08. This steady growth in dividends suggests a strategy focused on returning value to shareholders after the company’s earnings demonstrated stronger performance post-2013.
- Trends in Earnings Per Share
- Initial loss indicated in 2006 followed by growth through 2015.
- Peak earnings in 2014-2015 with values exceeding $10 per share.
- Subsequent decline to minimal earnings in 2020, partial recovery thereafter, ending with a drop in 2024.
- Dividend Policy
- No dividends paid until 2013.
- Consistent annual dividend growth from 2014 onward, reaching over $3 per share by 2024.
- Overall Insights
- The company showed volatile earnings performance with a notable peak period around 2014-2015.
- Dividends were introduced following sustained earnings improvement and have increased steadily, signaling a stable dividend policy.
- The pronounced drop in EPS around 2020 may reflect specific operational challenges or external factors impacting profitability.